$278.88
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Country

US

CEO

Mr. Adam Schechter

IPO date

1991

Employees

66,385

ISIN

US5049221055

Key stats

Open

$278.00

Volume

373.61K

Market cap

$22.77B

Prev. close

$277.63

Impl / hst vl

-

Open interest

$0.00

$276.00

Day’s Range

$280.85

$245.00

52W Range

$292.02

Valuation

61
Valuation score
Undervalued
P/E
24.18
P/S
1.61
P/B
2.61
Current ratio
1.73
Debt / Equity
0.62
ROE
10.91%
Gross margin
28.66%
Income growth
68.67%
FCF growth
-85.62

Jun

11

Dividends

The last payment date was Jun 11, 2026

Div. per Share

$0.72

Div. Yield

0.26%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 13 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$315.16
The top 21 analysts forecasts that 12-month price may increase by 13.01%, with a low of $272.70 and a high of $357.00
$272.70
Low
$315.16
Avg
$357.00
High
Current price

Earnings

Q1 ‘26 revenue
$3.54B
Q1 ‘26 net income
$277.80M
Revenue
Net income
Previous EPS
$4.25
Estimate EPS
$4.92
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply